Compare Lustrum:Astellas Pharma Inc.:4503

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Astellas Pharma Inc. Go to web site 4503 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Astellas Pharma Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Balance Sheet 2023年3月期 Astellas Pharma Inc. Balance Sheet 2022年3月期 Astellas Pharma Inc. Balance Sheet 2021年3月期 Astellas Pharma Inc. Balance Sheet 2020年3月期 Astellas Pharma Inc. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents
(Percent)
376,840up
(15.3%)up
315,986down
(13.5%)down
326,128up
(14.3%)up
318,391up
(13.8%)down
311,074
(16.4%)
Other Current AssetsHelp
(Percent)
673,114up
(27.4%)up
607,368up
(26.0%)up
546,460down
(24.0%)up
549,123up
(23.7%)down
546,085
(28.8%)
Tangible Fixed AssetsHelp
(Percent)
286,459up
(11.7%)up
269,044up
(11.5%)down
264,623down
(11.6%)up
268,600up
(11.6%)up
173,483
(9.1%)
Intangible Fixed AssetHelp
(Percent)
562,496down
(22.9%)down
623,431down
(26.7%)down
651,427down
(28.7%)down
724,773up
(31.3%)up
429,707
(22.6%)
Investments and OthersHelp
(Percent)
229,198up
(9.3%)up
213,536up
(9.2%)up
200,979up
(8.8%)up
176,029down
(7.6%)down
211,435
(11.1%)
Total AssetsHelp
(Percent)
2,456,518
(100%)
2,332,395
(100%)
2,273,628
(100%)
2,315,169
(100%)
1,897,648
(100%)
Total Current LiabilitiesHelp
(Percent)
808,640up
(32.9%)down
776,201up
(33.3%)up
688,492down
(30.3%)down
896,729up
(38.7%)up
586,370
(30.9%)
Total Long-term LiabilitiesHelp
(Percent)
139,924up
(5.7%)up
95,886down
(4.1%)down
199,021up
(8.8%)up
129,272up
(5.6%)up
52,882
(2.8%)
Shareholder's EquityHelp
(Percent)
1,507,954up
(61.4%)down
1,460,308up
(62.6%)up
1,386,115up
(61.0%)up
1,289,168up
(55.7%)down
1,258,396
(66.3%)
Total LiabilitiesHelp
(Percent)
2,456,518
(100%)
2,332,395
(100%)
2,273,628
(100%)
2,315,169
(100%)
1,897,648
(100%)

Astellas Pharma Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Profit and Loss Account 2023年3月期 Astellas Pharma Inc. Profit and Loss Account 2022年3月期 Astellas Pharma Inc. Profit and Loss Account 2021年3月期 Astellas Pharma Inc. Profit and Loss Account 2020年3月期 Astellas Pharma Inc. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales
(Percent)
1,518,619
(100%)
1,296,163
(100%)
1,249,528
(100%)
1,300,843
(100%)
1,306,348
(100%)
Total Sales
(Percent)
1,518,619
(100%)
1,296,163
(100%)
1,249,528
(100%)
1,300,843
(100%)
1,306,348
(100%)
Cost of SalesHelp
(Percent)
288,353up
(19.0%)down
253,009up
(19.5%)down
246,063down
(19.7%)down
276,739down
(21.3%)down
292,050
(22.4%)
Other Costs and RevenueHelp 1,131,552up
(74.5%)up
919,068up
(70.9%)up
882,875up
(70.7%)up
828,693up
(63.7%)up
792,033
(60.6%)
Total CostsHelp 1,419,905 1,172,077 1,128,938 1,105,432 1,084,083
Net RevenueHelp 1,230,266up
(81.0%)up
1,043,154up
(80.5%)up
1,003,465down
(80.3%)up
1,024,104up
(78.7%)up
1,014,298
(77.6%)
Earnings Before TaxHelp 132,361down
(8.7%)down
156,886up
(12.1%)up
145,324down
(11.6%)down
245,350down
(18.9%)down
248,967
(19.1%)
Net IncomeHelp 98,714down
(6.5%)down
124,086up
(9.6%)down
120,590down
(9.7%)down
195,411down
(15.0%)down
222,265
(17.0%)
当期純利益 98,714 124,086 120,590 195,411 222,265

Astellas Pharma Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Cash Flow Statement 2023年3月期 Astellas Pharma Inc. Cash Flow Statement 2022年3月期 Astellas Pharma Inc. Cash Flow Statement 2021年3月期 Astellas Pharma Inc. Cash Flow Statement 2020年3月期 Astellas Pharma Inc. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
327,767up
(96.1%)up
257,443down
(92.4%)down
306,843up
(96.2%)up
221,997down
(55.1%)down
256,899
(92.6%)
Investing Cash Flow(ICF)Help
(Percent)
-84,500down
(-24.8%)down
-62,413up
(-22.4%)up
-81,894up
(-25.7%)up
-389,793down
(-96.7%)down
-41,757
(-15.0%)
Financing Cash FlowHelp
(Percent)
-195,623up
(-57.4%)up
-216,298up
(-77.6%)down
-229,479down
(-71.9%)down
181,055up
(44.9%)up
-233,681
(-84.2%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
13,210up
(3.9%)down
11,125down
(4.0%)up
12,267up
(3.8%)up
-5,942down
(-1.5%)down
-2,118
(-0.8%)
Net Increase and Decrease in Cash and Cash Equivalentsn 60,854up
(17.8%)up
-10,143down
(-3.6%)down
7,737up
(2.4%)up
7,317up
(1.8%)up
-20,657
(-7.4%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Astellas Pharma Inc.

Company where related level is highHelp

KYORIN Pharmaceutical Co., Ltd.
FunPep Company Limited
ASKA Pharmaceutical Holdings Co., Ltd.
DAIICHI SANKYO COMPANY, LIMITED
SymBio Pharmaceuticals Limited
Nichi-Iko Pharmaceutical Co.,Ltd.
SAWAI PHARMACEUTICAL CO.,LTD.
ASKA Pharmaceutical Co.,Ltd.
Chiome Bioscience Inc.
Otsuka Holdings Co.,Ltd.